Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Antagonism of the interleukin 4 receptor α promotes TH 1-signalling among T cells from patients with atopic dermatitis after stimulation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Increased all-cause mortality in concomitant atopic dermatitis and asthma: A nationwide registry-based study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Chemicals in moisturizers may promote type 2 inflammation and food allergy

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  3. Nickel release from metallic earrings: A survey of the Danish market and validation of the nickel spot test

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Atopic dermatitis (AD) is a chronic and relapsing inflammatory skin disease. Molecular characterization of AD shows an underlying inflammation with tissue infiltration of T helper (TH ) 2 cells and increased IL-4 and IL-13. The multifaceted roles of IL-4 and IL-13 in allergic disease development make IL-4Rα an attractive target for treatment strategies, and a neutralizing monoclonal antibody which antagonizes the effects of both IL-4 and IL-13 by blocking the interaction site found in the IL-4 receptor subunit α (IL-4Rα) has been successfully used to treat patients with moderate-to-severe AD. To elucidate the effects of IL-4Rα blockade on the cellular level, we used flow cytometry to examine cytokine production after antigen stimulation in human T cells from patients with AD (n = 12) and healthy controls (n = 6). The cells were stimulated with and without a neutralizing monoclonal antibody against IL-4Rα. Our results indicate that blocking IL-4Rα prohibits IL-4 signalling and IL-13 signalling and thereby TH 2 differentiation followed by an upregulation of interferon-γ-producing cells.

TidsskriftScandinavian Journal of Immunology
Udgave nummer1
Sider (fra-til)e12835
StatusUdgivet - jan. 2020

Bibliografisk note

© 2019 The Scandinavian Foundation for Immunology.

ID: 58983207